Ignite Creation Date:
2025-12-24 @ 6:42 PM
Ignite Modification Date:
2026-03-13 @ 11:55 AM
Study NCT ID:
NCT02820857
Status:
COMPLETED
Last Update Posted:
2025-09-03
First Post:
2016-06-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Assessment of the Efficacy of Bevacizumab in Combination With Folfiri as Second-line Treatment in Patients Suffering From an Advanced Inoperable Poorly Differentiated Neuroendocrine Carcinoma of an Unknown or Gastroentero-pancreatic Primary Cancer
Sponsor:
Hospices Civils de Lyon
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
69HCL14_0442
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None